A. Zonana-nacach et al., Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis, LUPUS, 9(2), 2000, pp. 101-109
Objective: To determine the frequency, degree and associated features of fa
tigue among Hispanic (H), African American (AA) and Caucasian (C) patients
with recent onset (less than or equal to 5 yr) systemic lupus erythematosus
(SLE) at their baseline evaluation.
Methods: H (n = 69), AA (n = 83) acid C (n = 71) patients from the LUMINA (
LUpus in MInority populations: NAture vs Nurture) cohort were studied. Fati
gue [Fatigue Severity Scale (FSS)] was defined as present if FSS score grea
ter than or equal to 3.0. Variables from functional, clinical, sociodemogra
phic, health behaviors, behavioral and psychological and immunogenetics dom
ains were ascertained at study entry. Associations were examined using regr
ession models.
Results: Eighty-six percent (85.7%) of patients reported having fatigue (82
.6% H; 85.5% AA; 88.7% C); median FSS score, 5.3. Factors from the psycholo
gical and clinical domains were primarily associated with FSS; immunogeneti
c (HLA Class II phenotypes) features were not. Increased fatigue was strong
ly associated with decreasing function, both physical and mental. Variables
associated with significantly greater degree of fatigue at baseline in the
multivariable stepwise model in order of decreasing additional partial R-2
explained included: abnormal illness-related behaviors, older age, higher
self-reported pain, greater degree of helplessness, greater disease activit
y, Caucasian race, and lacking health insurance (model R-2 = 37%).
Conclusions: Fatigue is one of the most prevalent clinical manifestations o
f SLE across all ethnic groups. The perception of fatigue severity in SLE m
ay be multifactorial in origin, including psychosocial factors and disease
activity. If these prove causal, knowledge of their contribution may sugges
t therapeutic and/or behavioral interventions, which could ameliorate this
pervasive and often incapacitating symptom of SLE.